Citadel Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.1M Buy
184,963
+64,983
+54% +$23.2M 0.01% 1127
2025
Q4
$39.3M Sell
119,980
-30,868
-20% -$9.79M 0.01% 1643
2025
Q3
$42.6M Buy
150,848
+121,735
+418% +$35.3M 0.01% 1552
2025
Q2
$8.13M Buy
29,113
+9,108
+46% +$2.58M ﹤0.01% 3331
2025
Q1
$6.23M Sell
20,005
-504,498
-96% -$149M ﹤0.01% 3539
2024
Q4
$137M Buy
524,503
+516,699
+6,621% +$153M 0.02% 566
2024
Q3
$2.51M Sell
7,804
-15,010
-66% -$4.91M ﹤0.01% 5092
2024
Q2
$7.13M Sell
22,814
-105,368
-82% -$31M ﹤0.01% 3242
2024
Q1
$36.4M Buy
+128,182
New +$37.5M 0.01% 1471
2023
Q4
Sell
-40,987
Closed -$11.2M 14211
2023
Q3
$11M Sell
40,987
-326,544
-89% -$81.5M ﹤0.01% 2576
2023
Q2
$81.6M Buy
367,531
+66,044
+22% +$15.3M 0.02% 735
2023
Q1
$72.9M Buy
301,487
+235,907
+360% +$57.9M 0.02% 800
2022
Q4
$17.2M Sell
65,580
-49,638
-43% -$13.3M ﹤0.01% 2125
2022
Q3
$26M Sell
115,218
-285,026
-71% -$69.1M 0.01% 1623
2022
Q2
$97.4M Buy
400,244
+105,276
+36% +$25.8M 0.03% 587
2022
Q1
$71.3M Sell
294,968
-72,064
-20% -$16.6M 0.01% 850
2021
Q4
$82.6M Buy
367,032
+90,446
+33% +$19.1M 0.02% 793
2021
Q3
$58.8M Sell
276,586
-239,028
-46% -$55M 0.01% 1002
2021
Q2
$126M Buy
515,614
+351,638
+214% +$86.5M 0.03% 548
2021
Q1
$40.8M Sell
163,976
-68,716
-30% -$16.4M 0.01% 1225
2020
Q4
$53.5M Sell
232,692
-129,449
-36% -$29.8M 0.01% 906
2020
Q3
$92M Sell
362,141
-612,146
-63% -$152M 0.03% 505
2020
Q2
$230M Buy
974,287
+795,290
+444% +$181M 0.08% 146
2020
Q1
$36.3M Sell
178,997
-70,299
-28% -$15.4M 0.02% 807
2019
Q4
$60.1M Sell
249,296
-764,108
-75% -$168M 0.03% 666
2019
Q3
$196M Buy
1,013,404
+785,948
+346% +$151M 0.09% 162
2019
Q2
$41.9M Buy
227,456
+33,836
+17% +$6.06M 0.02% 852
2019
Q1
$36.8M Sell
193,620
-118,102
-38% -$22.6M 0.02% 870
2018
Q4
$60.7M Buy
311,722
+207,138
+198% +$40.4M 0.03% 526
2018
Q3
$21.7M Sell
104,584
-19,400
-16% -$3.82M 0.01% 1329
2018
Q2
$22.9M Buy
123,984
+14,658
+13% +$2.59M 0.01% 1204
2018
Q1
$18.6M Sell
109,326
-100,799
-48% -$18.5M 0.01% 1180
2017
Q4
$36.5M Buy
210,125
+186,858
+803% +$33.1M 0.02% 785
2017
Q3
$4.34M Sell
23,267
-44,727
-66% -$7.92M ﹤0.01% 2461
2017
Q2
$11.7M Sell
67,994
-13,206
-16% -$2.15M 0.01% 1345
2017
Q1
$13.3M Sell
81,200
-83,594
-51% -$13.9M 0.01% 1235
2016
Q4
$24.1M Sell
164,794
-141,422
-46% -$21.3M 0.02% 745
2016
Q3
$51.1M Buy
306,216
+292,530
+2,137% +$49.5M 0.05% 374
2016
Q2
$2.08M Sell
13,686
-225,271
-94% -$35M ﹤0.01% 2696
2016
Q1
$35.8M Sell
238,957
-435,595
-65% -$64.7M 0.05% 433
2015
Q4
$110M Sell
674,552
-41,214
-6% -$6.48M 0.12% 175
2015
Q3
$99M Buy
715,766
+603,620
+538% +$95.1M 0.09% 207
2015
Q2
$17.2M Buy
112,146
+38,854
+53% +$6.22M 0.01% 1101
2015
Q1
$11.7M Buy
73,292
+50,988
+229% +$8.03M 0.01% 1328
2014
Q4
$3.55M Sell
22,304
-216,199
-91% -$33.7M ﹤0.01% 2301
2014
Q3
$33.5M Buy
238,503
+5,132
+2% +$670K 0.04% 604
2014
Q2
$27.6M Buy
233,371
+99,328
+74% +$11.5M 0.03% 642
2014
Q1
$16.5M Sell
134,043
-86,696
-39% -$10.5M 0.02% 932
2013
Q4
$25.2M Buy
220,739
+8,188
+4% +$931K 0.03% 672
2013
Q3
$23.8M Sell
212,551
-117,052
-36% -$12.7M 0.04% 638
2013
Q2
$32.5M Buy
+329,603
New +$34.2M 0.06% 414

Other funds holding AMGN

Citadel Advisors's AMGN Position: Q1 2026 in Review

Citadel Advisors increased its Amgen (AMGN) stake by 54% in Q1 2026, buying an estimated $23.2M and bringing the position to 184,963 shares worth $65.1M. The position accounts for 0.01% of the portfolio, ranked #1127.

Citadel Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $230M in Q2 2020. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Citadel Advisors held 184,963 shares of Amgen worth $65.1M as of Q1 2026.
  • Citadel Advisors bought 64,983 Amgen shares in Q1 2026, an estimated $23.2M.
  • Amgen made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1127 holding.
  • Citadel Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Amgen position peaked at $230M in Q2 2020.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.